2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Consun Pharmaceutical Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability and PK of SK-09 SK-09, Placebo - FSGS, MCD | Phase 1 | Recruiting | Consun Pharmaceutical Group | 84 | 2025-12-08 | 2026-09-03 |
| A Study to Evaluate the Safety, Tolerability and PK of SK-08 SK-08, Placebo - Chronic Kidney Disease(CKD) | Phase 1 | Recruiting | Consun Pharmaceutical Group | 48 | 2025-03-09 | 2025-06-24 |
Macular dystrophy, corneal type 1 (1) · Renal Insufficiency, Chronic (1)
Australia (1) · China (1)